Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Phase I study of cediranib, an oral VEGFR inhibitor, in combination with selumetinib, an oral MEK inhibitor, in patients with advanced solid malignancies.
Journal: Investigational new drugs
Published: August 16, 2021
Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancer.
Journal: Gynecologic oncology
Published: July 16, 2021
Randomized Phase II Trial of Capecitabine and Lapatinib with or without IMC-A12 (Cituxumumab) in Patients with HER2-Positive Advanced Breast Cancer Previously Treated with Trastuzumab and Chemotherapy: NCCTG N0733 (Alliance).
Journal: Breast cancer research and treatment
Published: January 28, 2021
Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.
Journal: NPJ breast cancer
Published: November 23, 2020
Statistical analysis of comparative tumor growth repeated measures experiments in the ovarian cancer patient derived xenograft (PDX) setting.
Journal: Scientific reports
Published: September 25, 2020
Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 07, 2020
Disruption of Glycogen Utilization Markedly Improves the Efficacy of Carboplatin against Preclinical Models of Clear Cell Ovarian Carcinoma.
Journal: Cancers
Published: March 10, 2020
Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 11, 2020
Prognostic gene expression signature for high-grade serous ovarian cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: January 04, 2020
Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: September 17, 2019
Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer.
Journal: Theranostics
Published: October 16, 2018
Last Updated: 09/26/2026